Posted on 5월 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on 4월 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on 9월 30, 20249/30/24
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
Posted on 9월 13, 20249/13/24
Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets
Posted on 7월 22, 20247/22/24
AI’s Role in Drug Launches, Operations, and Drug Pricing: Q&A with Abid Rahman
Posted on 6월 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on 6월 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on 5월 13, 20245/13/24
Price Right or Pay Later
Posted on 4월 10, 20244/10/24
Understanding ICER’s 2024 Protocol for Assessing Unsupported Price Increases on Prescription Drugs
Posted on 3월 14, 20243/14/24